Emmanuel Chamorey

7.3k total citations
194 papers, 4.2k citations indexed

About

Emmanuel Chamorey is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Emmanuel Chamorey has authored 194 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Oncology, 68 papers in Pulmonary and Respiratory Medicine and 49 papers in Surgery. Recurrent topics in Emmanuel Chamorey's work include Head and Neck Cancer Studies (38 papers), Reconstructive Surgery and Microvascular Techniques (21 papers) and Breast Cancer Treatment Studies (17 papers). Emmanuel Chamorey is often cited by papers focused on Head and Neck Cancer Studies (38 papers), Reconstructive Surgery and Microvascular Techniques (21 papers) and Breast Cancer Treatment Studies (17 papers). Emmanuel Chamorey collaborates with scholars based in France, United States and Italy. Emmanuel Chamorey's co-authors include O. Dassonville, Alexandre Bozec, Gilles Poissonnet, F Démard, F. Ettore, Karen Bénézery, Jean-Marc Ferrero, Anne Sudaka, Jean‐Michel Hannoun‐Lévi and Frédéric Peyrade and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Emmanuel Chamorey

184 papers receiving 4.1k citations

Peers

Countries citing papers authored by Emmanuel Chamorey

Since Specialization

Citations

This map shows the geographic impact of Emmanuel Chamorey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Chamorey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Chamorey more than expected).

Fields of papers citing papers by Emmanuel Chamorey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Chamorey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Chamorey. The network helps show where Emmanuel Chamorey may publish in the future.

Co-authorship network of co-authors of Emmanuel Chamorey

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Chamorey. A scholar is included among the top collaborators of Emmanuel Chamorey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Chamorey. Emmanuel Chamorey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Organ preservation, for rectal cancer: general overview of the latest data from phase III randomized trials 2025 ·Acta Oncologica ·(unknown), (unknown), Diana M. Mitrea, Renaud Schiappa, (unknown), Emmanuel Chamorey, David Baron	0
2	The PROPHECI trial: a phase II, double-blind, placebo-controlled, randomized clinical trial for the treatment of pseudoxanthoma elasticum with oral pyrophosphate 2025 ·Trials ·(unknown), Isabelle Rubera, Christophe Duranton, Jocelyn Gal, Emmanuel Chamorey, (unknown), (unknown), C. Chiavérini, S. Willoteaux, B. Padovani, (unknown), (unknown), Stéphanie Baillif, Ludovic Martin, Georges Lefthériotis	3
3	EMOTION: Assessing the Impact of a Telephone Intervention for Patients With Breast Cancer, a Randomized Controlled Trial 2025 ·JCO Oncology Practice ·(unknown), Christophe Hébert, Jean-Marc Ferrero, (unknown), Véronique Mari, Laure Kaluzinski, Benjamin Hoch, Rémy Largillier, (unknown), (unknown), (unknown), Emmanuel Chamorey, Philippe Follana	0
4	Reproducibility of c-Met Immunohistochemical Scoring (Clone SP44) for Non–Small Cell Lung Cancer Using Conventional Light Microscopy and Whole Slide Imaging 2024 ·The American Journal of Surgical Pathology ·(unknown), Véronique Hofman, Emmanuel Chamorey, Renaud Schiappa, Sandra Lassalle, Élodie Long-Mira, Katia Zahaf, Salomé Lalvée, (unknown), Christelle Bonnetaud, (unknown), Marius Ilié, Paul Hofman	1
5	Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer 2024 ·International Journal of Molecular Sciences ·Emmanuel Chamorey, (unknown), Jean-Marc Ferrero, Hakim Mahammedi, Gwénaëlle Gravis, Guilhem Roubaud, Philippe Beuzeboc, Rémy Largillier, (unknown), Claude Linassier, (unknown), Marie-Christine Étienne-Grimaldi, Renaud Schiappa, Jocelyn Gal, G. Milano	0
6	Critical Appraisal and Future Challenges of Artificial Intelligence and Anticancer Drug Development 2024 ·Pharmaceuticals ·Emmanuel Chamorey, Jocelyn Gal, Baharia Mograbi, G. Milano	2
7	Artificial Intelligence and Anticancer Drug Development—Keep a Cool Head 2024 ·Pharmaceutics ·Caroline Bailleux, Jocelyn Gal, Emmanuel Chamorey, Baharia Mograbi, G. Milano	8
8	Salvage vs. Primary Total Laryngectomy in Patients with Locally Advanced Laryngeal or Hypopharyngeal Carcinoma: Oncologic Outcomes and Their Predictive Factors 2023 ·Journal of Clinical Medicine ·(unknown), Jocelyn Gal, Emmanuel Chamorey, Renaud Schiappa, O. Dassonville, Gilles Poissonnet, (unknown), (unknown), (unknown), Esma Saâda, Anne Sudaka, Dorian Culié, Alexandre Bozec	8
9	Validation of RUBY for Breast Cancer Knowledge Extraction From a Large French Electronic Medical Record System 2023 ·JCO Clinical Cancer Informatics ·Renaud Schiappa, (unknown), Dorian Culié, (unknown), Jocelyn Gal, (unknown), Caroline Bailleux, Juliette Haudebourg, Jean-Marc Ferrero, Emmanuel Barranger, Emmanuel Chamorey	3
10	Docetaxel-Cisplatin-Fluorouracil Induction Chemotherapy for Larynx Preservation in Patients with Locally Advanced Hypopharyngeal Cancer: Predictive Factors of Oncologic and Functional Outcomes 2023 ·Journal of Clinical Medicine ·(unknown), Jocelyn Gal, Emmanuel Chamorey, O. Dassonville, Gilles Poissonnet, (unknown), (unknown), (unknown), Esma Saâda, Anne Sudaka, Dorian Culié, Alexandre Bozec	3
11	Application of machine learning methods to guide patient management by predicting the risk of malignancy of Bethesda III-V thyroid nodules 2023 ·European Journal of Endocrinology ·(unknown), Jocelyn Gal, (unknown), O. Dassonville, Clair Vandersteen, N. Guevara, L. Castillo, Gilles Poissonnet, Dorian Culié, (unknown), Jérôme Sarini, (unknown), (unknown), S. Vergèz, Renaud Schiappa, Emmanuel Chamorey, (unknown), Alexandre Bozec	8
12	Myocarditis and COVID-19 Mrna Vaccines: A Mechanistic Hypothesis Involving dsRNA 2021 ·Future Virology ·G. Milano, Jocelyn Gal, (unknown), Emmanuel Chamorey	25
13	VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy—A Message from COMET, a French Unicancer Multicentric Study 2020 ·Pharmaceuticals ·Jocelyn Gal, G. Milano, Patrick Brest, Nathalie Ebran, Julia Gilhodes, (unknown), Coraline Dubot, Gilles Romieu, Isabelle Desmoulins, Étienne Brain, Anthony Gonçalvès, Jean-Marc Ferrero, Paul Cottu, Marc Debled, Olivier Trédan, Emmanuel Chamorey, Marco Merlano, Jérôme Lemonnier, Marie-Christine Étienne-Grimaldi, Jean‐Yves Pierga	7
14	Impact of HPV-associated p16-expression and other clinical factors on therapeutic decision-making in patients with oropharyngeal cancer: A GETTEC multicentric study 2018 ·European Journal of Surgical Oncology ·Dorian Culié, R. Garrel, Julien Viotti, Renaud Schiappa, Emmanuel Chamorey, Nicolas Fakhry, Benjamin Lallemant, S. Vergèz, Agnès Dupret‐Bories, O. Dassonville, G. Poissonnet, J. Santini, Frédéric Peyrade, Karen Bénézery, Anne Sudaka, (unknown), F. Chapel, Bruno Guelfucci, Alexandre Bozec	8
15	Detection of PD-L1 in circulating tumor cells and white blood cells from patients with advanced non-small-cell lung cancer 2017 ·Annals of Oncology ·Marius Ilié, Edith Szafer‐Glusman, Véronique Hofman, Emmanuel Chamorey, Salomé Lalvée, Éric Selva, Sylvie Leroy, Charles‐Hugo Marquette, Marcin Kowanetz, (unknown), Elizabeth A. Punnoose, Paul Hofman	153
16	The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma 2013 ·Cancer Research ·Renaud Grépin, Mélanie Guyot, Sandy Giuliano, (unknown), Damien Ambrosetti, Emmanuel Chamorey, Jean‐Yves Scoazec, Sylvie Négrier, Hélène Simonnet, Gilles Pagès	80
17	Central and peripheral venous port catheters: evaluation of patients? satisfaction under local anesthesia and Author's reply 2010 ·The Journal of Vascular Access ·Pierre‐Yves Marcy, (unknown), (unknown), Emmanuel Chamorey	1
18	A prospective multicenter study evaluating skin tolerance to standard hand hygiene techniques 2010 ·American Journal of Infection Control ·Emmanuel Chamorey, Pierre-Yves Marcy, (unknown), P. Veyres, (unknown), F. Vandenbos, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	27
19	Local Recurrence after Breast Cancer Affects Specific Survival Differently according to Patient Age 2010 ·Oncology ·A. Courdi, J. Doyen, (unknown), Emmanuel Chamorey	13
20	MRI for the size assessment of pure ductal carcinoma in situ (DCIS): A prospective study of 33 patients 2009 ·European Journal of Radiology ·(unknown), C. Balu–Maestro, Emmanuel Chamorey, F. Ettore, I. Raoust, B. Flipo, C. Chapellier	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact